Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
367
-
Total 13F shares, excl. options
-
56M
-
Shares change
-
+3.5M
-
Total reported value, excl. options
-
$9.86B
-
Value change
-
+$620M
-
Put/Call ratio
-
2.69
-
Number of buys
-
166
-
Number of sells
-
-174
-
Price
-
$176.07
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2015
416 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q2 2015.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 367 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56M shares
.
Largest 10 shareholders include FMR LLC (8.97M shares), PUTNAM INVESTMENTS LLC (8.41M shares), VANGUARD GROUP INC (3.88M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2.36M shares), Westpac Banking Corp (1.86M shares), JANUS CAPITAL MANAGEMENT LLC (1.63M shares), BlackRock Fund Advisors (1.52M shares), BlackRock Institutional Trust Company, N.A. (1.45M shares), STATE STREET CORP (1.18M shares), and Bank of New York Mellon Corp (1.11M shares).
This table shows the top 367 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.